These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

739 related items for PubMed ID: 21407186

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.
    Prefontaine E, Sutherland LR, Macdonald JK, Cepoiu M.
    Cochrane Database Syst Rev; 2009 Jan 21; (1):CD000067. PubMed ID: 19160175
    [Abstract] [Full Text] [Related]

  • 23. Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis.
    Ford AC, Kane SV, Khan KJ, Achkar JP, Talley NJ, Marshall JK, Moayyedi P.
    Am J Gastroenterol; 2011 Apr 21; 106(4):617-29. PubMed ID: 21407190
    [Abstract] [Full Text] [Related]

  • 24. Withdrawal of Azathioprine in Inflammatory Bowel Disease Patients Who Sustain Remission: New Risk Factors for Relapse.
    Iborra M, Herreras J, Boscá-Watts MM, Cortés X, Trejo G, Cerrillo E, Hervás D, Mínguez M, Beltrán B, Nos P.
    Dig Dis Sci; 2019 Jun 21; 64(6):1612-1621. PubMed ID: 30604371
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients.
    Kennedy NA, Kalla R, Warner B, Gambles CJ, Musy R, Reynolds S, Dattani R, Nayee H, Felwick R, Harris R, Marriott S, Senanayake SM, Lamb CA, Al-Hilou H, Gaya DR, Irving PM, Mansfield J, Parkes M, Ahmad T, Cummings JR, Arnott ID, Satsangi J, Lobo AJ, Smith M, Lindsay JO, Lees CW.
    Aliment Pharmacol Ther; 2014 Dec 21; 40(11-12):1313-23. PubMed ID: 25284134
    [Abstract] [Full Text] [Related]

  • 27. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J, Grancher K, Mandel F, Daum F.
    Am J Gastroenterol; 1993 Jan 21; 88(1):44-8. PubMed ID: 8420272
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [The use of methotrexate in an inflammatory bowel diseases based on the review of the current literature].
    Klimczak K, Łykowska-Szuber L, Krela-Kaźmierczak I, Eder P, Szymczak A, Stawczyk-Eder K, Linke K.
    Wiad Lek; 2016 Jan 21; 69(2 Pt 2):262-6. PubMed ID: 27487545
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine.
    Wahed M, Louis-Auguste JR, Baxter LM, Limdi JK, McCartney SA, Lindsay JO, Bloom SL.
    Aliment Pharmacol Ther; 2009 Sep 15; 30(6):614-20. PubMed ID: 19552632
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Cyclosporine for induction of remission in Crohn's disease.
    McDonald JW, Feagan BG, Jewell D, Brynskov J, Stange EF, Macdonald JK.
    Cochrane Database Syst Rev; 2005 Apr 18; (2):CD000297. PubMed ID: 15846602
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Methotrexate for maintenance of remission in Crohn's disease.
    Patel V, Macdonald JK, McDonald JW, Chande N.
    Cochrane Database Syst Rev; 2009 Oct 07; (4):CD006884. PubMed ID: 19821390
    [Abstract] [Full Text] [Related]

  • 38. Azathioprine: state of the art in inflammatory bowel disease.
    Sandborn WJ.
    Scand J Gastroenterol Suppl; 1998 Oct 07; 225():92-9. PubMed ID: 9515759
    [Abstract] [Full Text] [Related]

  • 39. Preoperative Use of Methotrexate and the Risk of Early Postoperative Complications in Patients with Inflammatory Bowel Disease.
    Afzali A, Park CJ, Zhu K, Hu JK, Sharma P, Sinanan MN, Lee SD.
    Inflamm Bowel Dis; 2016 Aug 07; 22(8):1887-95. PubMed ID: 27057681
    [Abstract] [Full Text] [Related]

  • 40. Efficacy, Safety and Mucosal Healing of Methotrexate in a Large Longitudinal Cohort of Inflammatory Bowel Disease Patients.
    Rouiller-Braunschweig C, Fournier N, Pittet V, Dudler J, Michetti P.
    Digestion; 2017 Nov 07; 96(4):220-227. PubMed ID: 29065423
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.